Skin rash could predict the response to EGFR tyrosine kinase inhibitor and the prognosis for patients with non-small cell lung cancer: a systematic review and meta-analysis.
<h4>Background</h4>The aim of this study was to assess the role of skin rash in predicting the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and the prognosis of patients with non-small cell lung cancer (NSCLC).<h4>Method</h4>We systemati...
Enregistré dans:
Auteurs principaux: | Hong-bing Liu, Ying Wu, Tang-feng Lv, Yan-wen Yao, Yong-ying Xiao, Dong-mei Yuan, Yong Song |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/98f5613a8b274eb4a0bafbfcb0dafa00 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines.
par: Jeet Gandhi, et autres
Publié: (2009) -
Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancer
par: Sangyong Jung, et autres
Publié: (2021) -
A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer
par: Natalia J. Gurule, et autres
Publié: (2021) -
First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitors
par: Nguyen KS, et autres
Publié: (2012) -
RANK-C Expression Sensitizes ER-Negative, EGFR-Positive Breast Cancer Cells to EGFR-Tyrosine Kinase Inhibitors (TKIs)
par: Chaido Sirinian, et autres
Publié: (2021)